(CI) Cigna - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1255231003
CI: Health, Pharmacy, Medicare, Dental, Insurance
Cigna Group, operating under the ticker symbol CI on the NYSE, is a prominent player in the health care services sector. As a multinational corporation founded in 1792 and headquartered in Bloomfield, Connecticut, Cigna specializes in providing a diverse array of insurance products and services. The company rebranded from Cigna Corporation to The Cigna Group in February 2023, reflecting its expanded scope and evolution in the health care industry.
Cignas operations are divided into two primary segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment offers a comprehensive suite of health services, including pharmacy benefits management, home delivery pharmacy services, specialty pharmacy offerings, distribution solutions, and care delivery and management services. These services are tailored to meet the needs of health plans, employers, government organizations, and health care providers, ensuring a coordinated approach to health management.
The Cigna Healthcare segment provides an extensive range of medical, pharmacy, behavioral health, and dental services. This segment also offers Medicare Advantage, Medicare Supplement, and Medicare Part D plans designed for seniors, as well as individual health insurance plans. Additionally, Cigna extends its coverage internationally, catering to mobile individuals and employees of multinational organizations, thus providing global health care benefits. The company also offers permanent insurance contracts and stop loss insurance, enhancing its product portfolio.
Cigna distributes its products and services through multiple channels, including insurance brokers and consultants, direct sales to employers, unions, groups, and individuals, as well as through private and public exchanges. This multifaceted approach ensures broad market reach and accessibility to a diverse customer base.
3-Month Forecast:
Based on the provided data, Cigna Corp (NYSE:CI) is expected to show continued growth. The stock is currently trading above its 20-day, 50-day, and 200-day moving averages, indicating a bullish trend. The average true range (ATR) of 8.98 suggests moderate volatility, so price fluctuations within this range are anticipated. The stock may consolidate or trend upwards, with potential support at the 20-day SMA (325.09) and resistance at recent highs (340.00).
From a fundamental perspective, Cignas forward P/E of 11.42 indicates expectations of earnings growth, despite the current P/E of 27.92. The price-to-sales ratio of 0.37 suggests the stock may be undervalued relative to its revenue. The return on equity (RoE) of 8.37% reflects moderate profitability. Overall, the company is well-positioned for potential long-term growth, driven by its diversified health care services and international presence.
Additional Sources for CI Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CI Stock Overview
| Market Cap in USD | 81,038m |
| Sector | Healthcare |
| Industry | Healthcare Plans |
| GiC Sub-Industry | Health Care Services |
| IPO / Inception | 1982-03-31 |
CI Stock Ratings
| Growth Rating | 42.4 |
| Fundamental | 40.9 |
| Dividend Rating | 68.4 |
| Rel. Strength | 0.93 |
| Analysts | 4.21/5 |
| Fair Price Momentum | 325.28 USD |
| Fair Price DCF | 482.64 USD |
CI Dividends
| Dividend Yield 12m | 2.27% |
| Yield on Cost 5y | 4.02% |
| Annual Growth 5y | 168.67% |
| Payout Consistency | 86.4% |
CI Growth Ratios
| Growth Correlation 3m | 66.2% |
| Growth Correlation 12m | -42.8% |
| Growth Correlation 5y | 89.9% |
| CAGR 5y | 11.42% |
| CAGR/Max DD 5y | 0.41 |
| Sharpe Ratio 12m | 0.61 |
| Alpha | -14.61 |
| Beta | 0.222 |
| Volatility | 29.51% |
| Current Volume | 2723.4k |
| Average Volume 20d | 1672.8k |
As of May 16, 2025, the stock is trading at USD 308.86 with a total of 2,723,351 shares traded.
Over the past week, the price has changed by -7.28%, over one month by -6.02%, over three months by +5.30% and over the past year by -8.48%.
Partly, yes. Based on ValueRay Fundamental Analyses, Cigna (NYSE:CI) is currently (May 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 40.86 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CI as of May 2025 is 325.28. This means that CI is currently overvalued and has a potential downside of 5.32%.
Cigna has received a consensus analysts rating of 4.21. Therefor, it is recommend to buy CI.
- Strong Buy: 12
- Buy: 5
- Hold: 7
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, CI Cigna will be worth about 351.3 in May 2026. The stock is currently trading at 308.86. This means that the stock has a potential upside of +13.74%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 375.1 | 21.5% |
| Analysts Target Price | 374.3 | 21.2% |
| ValueRay Target Price | 351.3 | 13.7% |